Development and Characterization of Cefoxitin Loaded D,L-PLA Nanoparticles
Nanoparticles containing cefoxitin (CEF) made of D,L-PLA (PLA) were designed by a multiple emulsion/solvent evaporation method. The particles were extensively evaluated in relation to morphology, encapsulation efficiency, drug-polymer interactions as well as in vitro drug release kinetics. Nanoparti...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
São Paulo State University (UNESP),
2010-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_24c903e50e4b48e89024f028b6548fe1 | ||
042 | |a dc | ||
100 | 1 | 0 | |a S.R.P. Machado |e author |
700 | 1 | 0 | |a R.C. Evangelista |e author |
245 | 0 | 0 | |a Development and Characterization of Cefoxitin Loaded D,L-PLA Nanoparticles |
260 | |b São Paulo State University (UNESP), |c 2010-09-01T00:00:00Z. | ||
500 | |a 1808-4532 | ||
500 | |a 2179-443X | ||
520 | |a Nanoparticles containing cefoxitin (CEF) made of D,L-PLA (PLA) were designed by a multiple emulsion/solvent evaporation method. The particles were extensively evaluated in relation to morphology, encapsulation efficiency, drug-polymer interactions as well as in vitro drug release kinetics. Nanoparticles were spherical in shape and isolated, with a mean diameter of about 600 nm. The thermal behaviour (DSC) of CEF-containing nanoparticles suggested that the drug was dispersed at a molecular level within the system. The drug encapsulation efficiency in the system for a CEF concentration of 30 mg/mL was 5.5%, as assessed after the drug extraction, by a validated HPLC method. This low encapsulation efficiency is understandable, since CEF is highly hydrophilic. The in vitro assays showed a strong sustained drug release profile from the nanoparticles with kinetics following pure Fickian diffusion. | ||
546 | |a EN | ||
690 | |a nanoparticles. controlled release. d,l-pla. cefoxitin. in vitro release. | ||
690 | |a Pharmaceutical industry | ||
690 | |a HD9665-9675 | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Revista de Ciências Farmacêuticas Básica e Aplicada, Vol 31, Iss 3 (2010) | |
787 | 0 | |n http://rcfba.fcfar.unesp.br/index.php/ojs/article/view/365 | |
787 | 0 | |n https://doaj.org/toc/1808-4532 | |
787 | 0 | |n https://doaj.org/toc/2179-443X | |
856 | 4 | 1 | |u https://doaj.org/article/24c903e50e4b48e89024f028b6548fe1 |z Connect to this object online. |